Therapeutic Strategies for Erectile Dysfunction With Emphasis on Recent Approaches in Nanomedicine

被引:7
作者
Ammar, Hussein O. [1 ]
Tadros, Mina I. [2 ]
Salama, Nahla M. [1 ]
Ghoneim, Amira M. [1 ]
机构
[1] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Pharmaceut & Pharmaceut Technol, New Cairo 11835, Egypt
[2] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo 12613, Egypt
关键词
Drugs; Arteries; Construction; Muscles; Biochemistry; Inhibitors; Plasmas; Erectile dysfunction; nanotechnology; phosphodiesterase; sildenafil; tadalafil; vardenafil; SOLID LIPID NANOPARTICLES; NITRIC-OXIDE SYNTHASE; PHOSPHODIESTERASE; 5; INHIBITOR; TOPICAL ALPROSTADIL CREAM; URINARY-TRACT SYMPTOMS; DRUG-DELIVERY-SYSTEM; STEM-CELL THERAPY; RISK-FACTORS; TRANSDERMAL DELIVERY; SILDENAFIL CITRATE;
D O I
10.1109/TNB.2019.2941550
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This review addressed erectile dysfunction, regarding pathophysiology and therapeutic strategies. The line of treatment includes phosphodiesterase type-5 inhibitors and other types of therapy like topical and stem-cell transplant. Scientific literature was assessed to investigate the impact of nanotechnology on erectile dysfunction therapy. Various nanotechnology approaches were applied, like vesicular systems, lipid-based carriers, nanocrystals, dendrimers, liquid crystalline systems and nanoemulsions. Smart nano-systems can alter the landscape of the modern pharmaceutical industry by re- investigation of pharmaceutically suboptimal but biologically active entities for treatment of erectile dysfunction which were previously considered undeveloped.
引用
收藏
页码:11 / 24
页数:14
相关论文
共 157 条
[1]  
Abeer S., 2012, J INT MED SCI ACAD, V25, P187
[2]   Two-Loop QCD correction to massive spin-2 resonance → 3 gluons [J].
Ahmed, Taushif ;
Mahakhud, Maguni ;
Mathews, Prakash ;
Rana, Narayan ;
Ravindran, V. .
JOURNAL OF HIGH ENERGY PHYSICS, 2014, (05) :1-45
[3]   Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction [J].
Al Suwaidi, J ;
Hamasaki, S ;
Higano, ST ;
Nishimura, RA ;
Holmes, DR ;
Lerman, A .
CIRCULATION, 2000, 101 (09) :948-954
[4]  
Albersen M., 2015, J SEX MED, V10, P1268
[5]   The future is today: emerging drugs for the treatment of erectile dysfunction [J].
Albersen, Maarten ;
Shindel, Alan W. ;
Mwamukonda, Kuwong B. ;
Lue, Tom F. .
EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (03) :467-480
[6]  
Ali MFM, 2015, DRUG DES DEV THER, V9, P2431, DOI [10.2147/DDDT.581236, 10.2147/DDDT.S81236]
[7]   Future prospects in the treatment of erectile dysfunction: focus on avanafil [J].
Alwaal, Amjad ;
Al-Mannie, Raed ;
Carrier, Serge .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 :435-443
[8]   Tadalafil for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Pathophysiology and Mechanism(s) of Action [J].
Andersson, Karl-Erik ;
de Groat, William C. ;
McVary, Kevin T. ;
Lue, Tom F. ;
Maggi, Mario ;
Roehrborn, Claus G. ;
Wyndaele, Jean Jacques ;
Melby, Thomas ;
Viktrup, Lars .
NEUROUROLOGY AND URODYNAMICS, 2011, 30 (03) :292-301
[9]   PHYSIOLOGY OF PENILE ERECTION [J].
ANDERSSON, KE ;
WAGNER, G .
PHYSIOLOGICAL REVIEWS, 1995, 75 (01) :191-236
[10]   Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer [J].
Annam, Kiran ;
Voznesensky, Maria ;
Kreder, Karl J. .
JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (04) :297-+